These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 14450094)

  • 1. [Effectiveness and mode of action of nialamide in peripheral, arterial circulatory disorders].
    HUPKA K; THALER H
    Chemotherapia (Basel); 1962; 4():102-11. PubMed ID: 14450094
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of peripheral ischemic disorders with Niamid].
    FABRE J; LINDHEIMER M; MICHEL B
    Chemotherapia (Basel); 1962; 4():78-101. PubMed ID: 13891220
    [No Abstract]   [Full Text] [Related]  

  • 3. Preliminary observations on the role of monoamine oxidase inhibitors in the therapy of peripheral arterial disease.
    SAMUELS SS; SHAFTEL HE
    Angiology; 1960 Feb; 11():90-2. PubMed ID: 14441293
    [No Abstract]   [Full Text] [Related]  

  • 4. THE PLACE OF MONOAMINE OXIDASE INHIBITOR IN OCCLUSIVE PERIPHERAL VASCULAR DISEASE.
    CHHETRI MK; GUHA SR
    J Indian Med Assoc; 1965 Feb; 44():172-7. PubMed ID: 14272637
    [No Abstract]   [Full Text] [Related]  

  • 5. [On the circulatory action of Niamid in atopic diseases].
    STORCK H; HEIM E; KONZELMANN M
    Chemotherapia (Basel); 1962; 4():196-202. PubMed ID: 13917507
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of nialamide on endogenously and exogenously elevated blood ammonia levels in patients with liver disease.
    BEAL RW; BLACKBURN CR
    Australas Ann Med; 1962 Feb; 11():19-23. PubMed ID: 13866111
    [No Abstract]   [Full Text] [Related]  

  • 7. [Peripheral circulatory effect of "Niamid"].
    SCHELLING JL
    Chemotherapia (Basel); 1962; 4():112-8. PubMed ID: 14498199
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical-experimental studies on the indications and action of 1-(2-benzylcarbamylethyl)-2-isonicotinoyhydrazine (Nialamide)].
    KNICK B
    Arzneimittelforschung; 1961 Sep; 11():843-7. PubMed ID: 14457227
    [No Abstract]   [Full Text] [Related]  

  • 9. [Action of a monoamine oxidase inhibitor (Niamid) on various experimental vascular lesions in the rabbit (allergic arteritis, myocardial necrosis caused by isoproterenol, aortic medionecrosis, venous and arterial thrombosis)].
    FABRE J; RUDHARDT M; MICHEL B; LACOURT G; JEANDET J
    Chemotherapia (Basel); 1962; 4():237-47. PubMed ID: 13891221
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical and experimental data on the neurohumoral vascular and tissue effects of nialamide in cardiovascular and metabolic diseases].
    KNICK B
    Chemotherapia (Basel); 1962; 4():297-303. PubMed ID: 14457226
    [No Abstract]   [Full Text] [Related]  

  • 11. Antithrombotic effect of monamine oxidase inhibitor (nialamide).
    SHIMAMOTO T; ISHIOKA T; FUJITA T
    Circ Res; 1962 Apr; 10():647-57. PubMed ID: 13911935
    [No Abstract]   [Full Text] [Related]  

  • 12. [Rheographic observations in the course of treatment with monoamine oxidase inhibitors in diabetic vasculopathy].
    CALIFANO A; IRONE J
    Gazz Int Med Chir; 1962 May; 66():974-81. PubMed ID: 13875739
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hydrotherapy of peripheral arterial circulatory disorders].
    BRUEGGEMANN W
    Izv Bulg Akad Naukite Sofia Nauchnoizsledovatelski Inst protivorak antibiot; 1961 Dec; 2():711-6. PubMed ID: 13873882
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical-experimental research on the action of Niamid on hemodynamics and coagulation].
    KLEIN K
    Chemotherapia (Basel); 1962; 4():203-9. PubMed ID: 14456757
    [No Abstract]   [Full Text] [Related]  

  • 15. [On the therapy of arterial peripheral circulatory diseases].
    BUSCHMANN W
    Z Gesamte Inn Med; 1960 Feb; 15():187-97. PubMed ID: 13806386
    [No Abstract]   [Full Text] [Related]  

  • 16. [ELECTROENCEPHALOGRAPHIC REPORTS IN AGED SUBJECTS TREATED WITH DRUGS WITH AN MONOAMINE OXIDASE INHIBITOR ACTION (NIALAMIDE)].
    SAVOLDI F; COSI V; TAMMARO AE
    G Gerontol; 1964 Sep; 12():1109-13. PubMed ID: 14258420
    [No Abstract]   [Full Text] [Related]  

  • 17. [THE ACTION OF A MONOAMINE OXIDASE INHIBITOR ON THE SIZE OF VENOUS AND ARTERIAL THROMBOSES].
    FABRE J; RUDHARDT M; MICHEL B
    Schweiz Med Wochenschr; 1964 Jun; 94():894-7. PubMed ID: 14238347
    [No Abstract]   [Full Text] [Related]  

  • 18. [ON METHODS OF PRODUCTION OF EXPERIMENTAL THROMBOSIS IN RABBIT EARS AND THE SIGNIFANCE OF 5-HYDROXYTRYPTAMINE IN THEIR FORMATION].
    BAUMGARTNER HR; STUDER A; REBER K
    Thromb Diath Haemorrh; 1963 Jul; 18():485-511. PubMed ID: 14072242
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cardiac catecholamines after ligation of the coronary artery. Influence of a monoaminoxidase inhibitor (nialamide) on the infarct].
    SERRANO PA; VILLANUEVA SA; LERDO DE TEJADAHAY A; CASTANEDA Y; CHAVEZ LARA B; BISTENI A
    Arch Inst Cardiol Mex; 1961; 31():197-204. PubMed ID: 13910885
    [No Abstract]   [Full Text] [Related]  

  • 20. [Peripheral arterial circulatory disorders and therapy. I. Rheoangiographic registration of the effect of nitroglycerin preparations in healthy subjects].
    HUEBER EF; THALER H; WICK E
    Z Kreislaufforsch; 1956 Jun; 45(11-12):432-9. PubMed ID: 13338483
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.